Antiseptic Irrigation for Pleural Infection
Launched by ALEXANDRIA UNIVERSITY · Feb 17, 2021
Trial Information
Current as of June 14, 2025
Completed
Keywords
ClinConnect Summary
Pleural infection is a condition that requires hospitalization for management and is associated with significant in-hospital morbidity and mortality. Predictors of poor outcome include advancing age, poor nutrition, hospital-acquired infection and impaired renal function. Medical management is centred on appropriate antibiotic treatment and fluid drainage usually by the means of an intercostal tube. Up to 30% of patients fail medical treatment and referred for surgery. A recent systematic review of adults patient with pleural infection has shown that the demographics of patients with pleura...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All adult patients admitted to hospital with pleural infection and had a chest tube inserted for treatment of the infection. Pleural infection will be defined by the presence of one of the following: a) the presence of pus in the pleural space; b) positive pleural fluid gram stain or culture; or c) pleural fluid pH \< 7.2 or pleural fluid glucose \< 40 mg/dL in the setting of acute respiratory infection.
- • Pleural collection is unilocular on pre-drainage imaging. Presence of septations on ultrasound examination is allowed.
- Exclusion Criteria:
- • Known or suspected thyroid disease
- • Allergy to iodine
- • Persistent large collection on follow up imaging 24-48 of post tube insertion that requires another drainage procedure
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, , Egypt
Patients applied
Trial Officials
Maged Hassan, PhD
Principal Investigator
Alexandria Faculty of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials